Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in biotech dealmaking

2.1. Introduction
2.2. Biotech partnering over the years
2.3. Most active biotech dealmakers
2.4. Biotech partnering by deal type
2.5. Biotech partnering by therapy area
2.6. Biotech partnering by technology type
2.7. Deal terms for biotech partnering
2.7.1 Biotech partnering headline values
2.7.2 Biotech deal upfront payments
2.7.3 Biotech deal milestone payments
2.7.4 Biotech royalty rates

Chapter 3 – Leading biotech deals

3.1. Introduction
3.2. Top biotech deals by value

Chapter 4 – Most active biotech dealmakers

4.1. Introduction
4.2. Most active biotech dealmakers
4.3. Most active biotech partnering company profiles

Chapter 5 – Biotech contracts dealmaking directory

5.1. Introduction
5.2. Biotech contracts dealmaking directory

Chapter 6 – Biotech dealmaking by technology type

Appendices

Appendix 1 – Biotech deals by company A-Z
Appendix 2 – Biotech deals by stage of development
Appendix 3 – Biotech deals by deal type
Appendix 4 – Biotech deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further reading

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Biotech partnering since 2018
Figure 2: Active biotech dealmaking activity– 2018 to 2023
Figure 3: Biotech partnering by deal type since 2018
Figure 4: Biotech partnering by disease type since 2018
Figure 5: Biotech partnering by technology type since 2018
Figure 6: Biotech deals with a headline value
Figure 7: Biotech deals with an upfront value
Figure 8: Biotech deals with a milestone value
Figure 9: Biotech deals with a royalty rate value
Figure 10: Top biotech deals by value since 2018
Figure 11: Most active biotech dealmakers 2018 to 2023